OPKO Health/$OPK

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About OPKO Health

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

Ticker

$OPK
Primary listing

Industry

Health Care Providers & Services

Employees

2,997

ISIN

US68375N1037

OPKO Health Metrics

BasicAdvanced
$1B
-
-$0.06
1.42
-

What the Analysts think about OPKO Health

Analyst ratings (Buy, Hold, Sell) for OPKO Health stock.

Bulls say / Bears say

OPKO Health reported a net income of $14.0 million in Q4 2024, a significant turnaround from the $66.5 million net loss in the same quarter of the previous year, indicating improved financial performance. (stocktitan.net)
The company secured $51 million in additional funding from BARDA for COVID and influenza programs, enhancing its research and development capabilities. (stocktitan.net)
OPKO Health announced a $100 million increase to its existing share repurchase program, demonstrating confidence in its financial position and commitment to returning value to shareholders. (reuters.com)
Despite the net income in Q4 2024, OPKO Health reported an operating loss of $33.1 million in the same quarter, indicating ongoing operational challenges. (stocktitan.net)
Product revenue declined to $37.4 million in Q4 2024 from $43.0 million in the previous year, reflecting potential issues in product sales performance. (stocktitan.net)
Diagnostic services revenue decreased to $103.1 million in Q4 2024 from $124.2 million year-over-year, suggesting a downturn in this segment. (stocktitan.net)
Data summarised monthly by Lightyear AI. Last updated on 8 Jun 2025.

OPKO Health Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

OPKO Health Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $OPK

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs